share_log

Galectin Therapeutics | 8-K/A: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

SEC ·  Nov 13, 2023 22:21
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.